4//SEC Filing
Richard Robert E. 4
Accession 0000899243-20-017762
CIK 0001327273other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:18 PM ET
Size
5.6 KB
Accession
0000899243-20-017762
Insider Transaction Report
Form 4
Richard Robert E.
SVP of R&D
Transactions
- Award
Stock Option
2020-06-24+35,000→ 35,000 totalExercise: $12.33Exp: 2030-06-24→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 25% of the shares on June 23, 2021 and in 36 equal monthly installments thereafter.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001816151
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:18 PM ET
- Size
- 5.6 KB